● INNOVATING OPTHALMIC CARE
Transforming
Ophthalmology
Through
Intelligence
When up to 50% of participants don't adhere to their eye drop treatment regimen, true treatment value is lost. This same challenge limits both clinical trials success and real-world care. We deliver integrated precision care that drives regimen adherence to topical ophthalmic medications.
What Does Vysum Offer?
Eliminate Ambiguity
Remove the uncertainty between drug failure and non-adherence, significantly improving clinical trial success rates
Real-time Intelligence
Fully automated adherence survillance that reduces site monitoring costs and improves statistical power
Preserving Vision
Addressing multifactorial barriers in routine care to prevent irreversible blindness in aging populations
The Blind Spot in Ophthalmic Care
Despite being a cornerstone of treatment, adherence to eye drop treatment is difficult to measure. Self-reporting overestimate adherence by up to 20%, leading to clinicians working in the dark.
80%Non-adherence in glaucoma patients
20%Overestimated adherence in patient self-report
The Ocumate
A semi-automated electromechanical system designed to solve dexterity barriers and ensure consistent administration technique.
Assisted drop delivery
Encourage independence
Adherence data for better condition management
The "Last Mile" of Eye Drop Delivery
In clinical trials, non-adherence increases variability and elevates the risk of statistical errors, leading to costly failures of therapeutic candidates.
32.6%Average ophthalmic drug go-to-market success rate
30%Drop in adherence by day 100 of a trial
IRISS System
The FlRST technology to objectively confirm drug-ocular contact using millisecond-scale sensor fusion and AI-driven computer vision.
Objective Ocular confirmation
Real-time Remote Surveillance
Building Future Standards for Trial Quality and Patient Care